Evidence map›Paper›PMID 35357814›Full record

ArticleACS biomaterials science & engineering2022

Microbubble Size and Dose Effects on Pharmacokinetics.

J Angel Navarro-Becerra, Kang-Ho Song, Payton Martinez, Mark A Borden

Open access · greenAbstract read
In one paragraph

Article in ACS biomaterials science & engineering, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Ultrasound-responsive composite hydrogels: Design rules for spatiotemporally controlled drug delivery.Journal of controlled release : official journal of the Controlled Release Society · 2026
    Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Frequency-Selective Microbubble TargetingACS applied bio materials · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

J Angel Navarro-BecerraMechanical Engineering Department, University of Colorado, Boulder, Colorado 80309, United States.ORCID 0000-0002-5974-3971
Kang-Ho SongMechanical Engineering Department, University of Colorado, Boulder, Colorado 80309, United States.
Payton MartinezBiomedical Engineering Program, University of Colorado, Boulder, Colorado 80309, United States.ORCID 0000-0003-2634-9502
Mark A BordenMechanical Engineering Department, University of Colorado, Boulder, Colorado 80309, United States.ORCID 0000-0002-2089-983X
University of Colorado Boulder · US

Funding

Microbubble Dose Optimization for Image-Guided Drug DeliveryR01CA239465 · NCI · UNIVERSITY OF COLORADO · PI BORDEN, MARK ANDREW · 2019 to 2023
$1.7M
NCI NIH HHS R01 CA239465
6 · The paper itself

Abstract

Optimization of contrast-enhanced imaging and focused ultrasound therapy requires a comprehensive understanding of in vivo microbubble (MB) pharmacokinetics. Prior studies have focused pharmacokinetic analysis on indirect techniques, such as ultrasound imaging of the blood pool and gas chromatography of exhaled gases. The goal of this work was to measure the MB concentration directly in blood and correlate the pharmacokinetic parameters with the MB size and dose. MB volume dose (MVD) was chosen to combine the size distribution and number into a single-dose parameter. Different MB sizes (2, 3, and 5 μm diameter) at 5-40 μL/kg MVD were intravenously injected. Blood samples were withdrawn at different times (1-10 min) and analyzed by image processing. We found that for an MVD threshold < 40 μL/kg for 2 and 3 μm and <10 μL/kg for 5 μm, MB clearance followed first-order kinetics. When matching MVD, MBs of different sizes had comparable half-lives, indicating that gas dissolution and elimination by the lungs are the primary mechanisms for elimination. Above the MVD threshold, MB clearance followed biexponential kinetics, suggesting a second elimination mechanism mediated by organ retention, possibly in the lung, liver, and spleen. In conclusion, we present the first direct MB pharmacokinetic study, demonstrate the utility of MVD as a unified dose metric, and provide insights into the mechanisms of MB clearance from circulation.

Indexed as

GasesMicrobubblesUltrasonographyGasesbiexponential kineticsdirect blood measurementsfirst-order kineticsmicrobubble pharmacokineticsmicrobubble volume dose

Identifiers

PMID35357814
PMCPMC9175185
OpenAlexW4221044225

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.